2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Acanthosis Nigricans: new trials by email Literature Review of Acanthosis Nigricans trials Research Report on Acanthosis Nigricans
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Efficacy of Topical Sirolimus 0.2% to Treat Acanthosis Nigricans Sirolimus 0.2% - Acanthosis Nigricans | Phase 2 | Completed | Narrows Institute for Biomedical Research | 5 | 2025-03-01 | 2025-11-28 |
| Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome leuprolide acetate, spironolactone - Acanthosis Nigricans, Polycystic Ovary Syndrome | Phase 2 | Completed | National Center for Research Resources (NCRR) | 1989-07-01 | 2005-06-24 |
Endocrine System Diseases (1) · Polycystic Ovary Syndrome (1) · Rare Diseases (1) · Skin Diseases (1)
Hyperpigmentation (2) · Melanosis (2) · Pigmentation Disorders (2) · Skin and Connective Tissue Diseases (2) · Adnexal Diseases (1) · Cysts (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Gonadal Disorders (1) · Neoplasms (1) · Ovarian Cysts (1) · Ovarian Diseases (1)
Leuprolide (1) · Spironolactone (1)
Narrows Institute for Biomedical Research (1) · National Center for Research Resources (NCRR) (1)
United States (1)
Jared Jagdeo, MD MS (1) · Karen E. Elkind-Hirsch (1)